Clinical trial
A Clinical Efficacy Study of Mazdutide in the Treatment of Polycystic Ovary Syndrome
NCT06519656 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Clinical Efficacy Study of Mazdutide in the Treatment of Polycystic Ovary Syndrome
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- October 21, 2024
- Completion date
- September 18, 2026
- Enrollment
- 43 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.